XML 44 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefit Plans (Tables)
6 Months Ended
Dec. 31, 2020
Share Based Compensation [Abstract]  
Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

 

 

December 31,

2020

 

 

June 30,

2020

 

2013 Equity Incentive Plan shares available for grant

 

 

6,149

 

 

 

13,118

 

Employee stock options and awards outstanding

 

 

12,478

 

 

 

10,396

 

2014 Employee Stock Purchase Plan

 

 

5,913

 

 

 

7,364

 

Total shares reserved for issuance

 

 

24,540

 

 

 

30,878

 

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

December 31,

2020

 

 

December 31,

2019

 

 

December 31,

2020

 

 

December 31,

2019

 

Cost of product revenues

 

$

314

 

 

$

402

 

 

$

572

 

 

$

652

 

Cost of service and subscription revenues

 

 

439

 

 

 

505

 

 

 

811

 

 

 

852

 

Research and development

 

 

2,694

 

 

 

3,260

 

 

 

4,966

 

 

 

5,695

 

Sales and marketing

 

 

3,239

 

 

 

3,511

 

 

 

5,886

 

 

 

7,230

 

General and administrative

 

 

3,409

 

 

 

2,801

 

 

 

6,162

 

 

 

4,884

 

Integration costs

 

 

 

 

 

479

 

 

 

 

 

 

479

 

Total share-based compensation expense

 

$

10,095

 

 

$

10,958

 

 

$

18,397

 

 

$

19,792

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended December 31, 2020 (in thousands, except per share and contractual term):

 

 

Number of Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Options outstanding at June 30, 2020

 

 

2,922

 

 

$

4.95

 

 

 

3.09

 

 

$

1,688

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(19

)

 

 

4.39

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(600

)

 

 

5.30

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2020

 

 

2,303

 

 

$

4.87

 

 

 

3.33

 

 

$

4,653

 

Vested and expected to vest at December 31, 2020

 

 

2,303

 

 

$

4.87

 

 

 

3.33

 

 

$

4,653

 

Exercisable at December 31, 2020

 

 

1,262

 

 

$

3.50

 

 

 

1.89

 

 

$

4,274

 

Summary of Stock Award Activity

The following table summarizes stock award activity for the six months ended December 31, 2020 (in thousands, except grant date fair value):

 

 

 

Number of Shares

 

 

Weighted- Average Grant Date Fair Value

 

 

Aggregate Fair Market Value

 

Non-vested stock awards outstanding at June 30, 2020

 

 

7,474

 

 

$

6.83

 

 

 

 

 

Granted

 

 

5,703

 

 

 

4.70

 

 

 

 

 

Released

 

 

(2,342

)

 

 

7.24

 

 

 

 

 

Cancelled

 

 

(660

)

 

 

9.37

 

 

 

 

 

Non-vested stock awards outstanding at December 31, 2020

 

 

10,175

 

 

$

5.37

 

 

$

70,104

 

Vested and expected to vest at December 31, 2020

 

 

9,709

 

 

$

5.32

 

 

$

66,864

 

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs) The MSU award represents the right to receive a target number of shares of common stock up to 150% of the original grant. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods from August 15, 2020 through August 15, 2023, subject to the grantees’ continued service through the certification of performance.

Level

Relative TSR

Shares Vested

 

Below Threshold

TSR is less than the Index by more than 37.5 percentage points

0%

 

Threshold

TSR is less than the Index by 37.5 percentage points

25%

 

Target

TSR equals the Index

100%

 

Maximum

TSR is greater than the Index by 25 percentage points or more

150%

 

 

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

 

 

 

Employee Stock Purchase Plan

 

 

 

Six Months Ended

 

 

 

December 31,

2020

 

 

December 31,

2019

 

Expected life

 

0.5 years

 

 

0.5 years

 

Risk-free interest rate

 

 

0.12

%

 

 

1.85

%

Volatility

 

 

119

%

 

 

43

%

Dividend yield

 

 

%

 

 

%